Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel
- Citation:
- Cancer Treat Rev vol 34 (3) 223-230
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA047577, U10 CA032291, CA33601, U10 CA035279, U10 CA031946, U10 CA033601, U10 CA031946-27, U10 CA047642, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Minetta C. Liu George D. Demetri Donald A. Berry Larry Norton Gloria Broadwater Nicholas J. Robert David Duggan Daniel F. Hayes I.Craig Henderson Alan Lyss Judith Hopkins Peter A. Kaufman P. Kelly Marcom Jerry Younger Nancy Lin Katherine Tkaczuk Eric P. Winer Clifford A. Hudis
- Networks:
- Study
- Alliance-9141
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Article